Keywords: dov, closes, deal, merck, co, novel, triple

DOV closes deal with Merck & Co for novel triple uptake inhibitors

Article | 20 September 2004

Print This

DOV Pharmaceutical says it has closed a licensing deal with anaffiliate of drug major Merck & Co for the development and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in